5-FU, a key drug in both PDAC and CRC treatment, induces p53-mediated apoptosis by caspase 3 cleavage in p53+/+ mice while this phenomenon is greatly reduced in p53–/– mice or p53 wild type with peripheral LIF infusion. Here, LIF is linked to colorectal carcinoma.